Uncommon genetic aberrations NTRK, RET, NRG
Uncommon genetic aberrations NTRK, RET, NRG
ASCO 2024: Lung cancer highlights
Encouraging results using mismatched unrelated donors in stem cell transplantation
Best practice in HRRm testing in patients with metastatic prostate cancer
Trial argues strongly for the development of 1st-line biomarker selected strategies in pancreatic ductal adenocarcinoma
ARV-766 well tolerated and shows promising clinical activity in metastatic castration-resistant prostate cancer
ASCO 2024: Highlights and analysis
Clinical behaviour of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing
Daratumumab plus bortezomib/lenalidomide/dexamethasone in transplant-eligible patients with NDMM: MRD analysis
Looking at real world evidence on PSA testing in prostate cancer
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
Treatment of multiple myeloma in Turkey